NO911236L - Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer. - Google Patents
Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.Info
- Publication number
- NO911236L NO911236L NO91911236A NO911236A NO911236L NO 911236 L NO911236 L NO 911236L NO 91911236 A NO91911236 A NO 91911236A NO 911236 A NO911236 A NO 911236A NO 911236 L NO911236 L NO 911236L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- haloethyl
- enzymin
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Paper (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50319190A | 1990-04-02 | 1990-04-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO911236D0 NO911236D0 (no) | 1991-03-26 |
| NO911236L true NO911236L (no) | 1991-10-03 |
Family
ID=24001090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91911236A NO911236L (no) | 1990-04-02 | 1991-03-26 | Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0450515B1 (no) |
| JP (1) | JP3058710B2 (no) |
| KR (1) | KR0186004B1 (no) |
| CN (1) | CN1055365A (no) |
| AT (1) | ATE124952T1 (no) |
| AU (1) | AU636023B2 (no) |
| CA (1) | CA2038985C (no) |
| DE (1) | DE69111108T2 (no) |
| ES (1) | ES2077097T3 (no) |
| FI (1) | FI911529A (no) |
| HU (1) | HUT57232A (no) |
| IE (1) | IE911062A1 (no) |
| IL (1) | IL97696A0 (no) |
| NO (1) | NO911236L (no) |
| NZ (1) | NZ237559A (no) |
| PT (1) | PT97202A (no) |
| ZA (1) | ZA912235B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3449381A (en) * | 1962-06-12 | 1969-06-10 | Syntex Corp | 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives |
| US3213085A (en) * | 1962-06-12 | 1965-10-19 | Syntex Corp | 19-lower alkyl-delta4-pregnen-20-one derivatives |
| GB8531747D0 (en) * | 1985-12-24 | 1986-02-05 | Erba Farmitalia | 10beta-alkynylestrene derivatives |
| GB8531743D0 (en) * | 1985-12-24 | 1986-02-05 | Erba Farmitalia | 10beta-halo-alkynyl-estrene derivatives |
-
1991
- 1991-03-25 NZ NZ237559A patent/NZ237559A/xx unknown
- 1991-03-25 ZA ZA912235A patent/ZA912235B/xx unknown
- 1991-03-25 CA CA002038985A patent/CA2038985C/en not_active Expired - Fee Related
- 1991-03-26 AU AU73784/91A patent/AU636023B2/en not_active Ceased
- 1991-03-26 NO NO91911236A patent/NO911236L/no unknown
- 1991-03-27 IL IL97696A patent/IL97696A0/xx unknown
- 1991-03-28 AT AT91105003T patent/ATE124952T1/de not_active IP Right Cessation
- 1991-03-28 EP EP91105003A patent/EP0450515B1/en not_active Expired - Lifetime
- 1991-03-28 ES ES91105003T patent/ES2077097T3/es not_active Expired - Lifetime
- 1991-03-28 IE IE106291A patent/IE911062A1/en unknown
- 1991-03-28 DE DE69111108T patent/DE69111108T2/de not_active Expired - Fee Related
- 1991-03-28 PT PT97202A patent/PT97202A/pt not_active Application Discontinuation
- 1991-03-28 FI FI911529A patent/FI911529A/fi unknown
- 1991-03-29 HU HU911038A patent/HUT57232A/hu unknown
- 1991-03-30 KR KR1019910005136A patent/KR0186004B1/ko not_active IP Right Cessation
- 1991-04-01 CN CN91102036A patent/CN1055365A/zh active Pending
- 1991-04-02 JP JP3094976A patent/JP3058710B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO911236D0 (no) | 1991-03-26 |
| CA2038985C (en) | 2002-10-15 |
| AU7378491A (en) | 1991-10-03 |
| HUT57232A (en) | 1991-11-28 |
| ATE124952T1 (de) | 1995-07-15 |
| KR910018402A (ko) | 1991-11-30 |
| EP0450515A2 (en) | 1991-10-09 |
| JPH04253994A (ja) | 1992-09-09 |
| DE69111108T2 (de) | 1996-01-18 |
| IL97696A0 (en) | 1992-06-21 |
| CA2038985A1 (en) | 1991-10-03 |
| NZ237559A (en) | 1993-04-28 |
| EP0450515B1 (en) | 1995-07-12 |
| IE911062A1 (en) | 1991-10-09 |
| DE69111108D1 (de) | 1995-08-17 |
| HU911038D0 (en) | 1991-10-28 |
| KR0186004B1 (ko) | 1999-04-01 |
| FI911529A0 (fi) | 1991-03-28 |
| PT97202A (pt) | 1991-11-29 |
| ES2077097T3 (es) | 1995-11-16 |
| AU636023B2 (en) | 1993-04-08 |
| CN1055365A (zh) | 1991-10-16 |
| FI911529A (fi) | 1991-10-03 |
| EP0450515A3 (en) | 1992-09-30 |
| ZA912235B (en) | 1991-12-24 |
| JP3058710B2 (ja) | 2000-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9302876A (es) | Inhibidores de doble accion. | |
| ATE211732T1 (de) | N-benzylpiperidin- und tetrahydropyridin-derivate | |
| ATE192649T1 (de) | Stereochemische wortmanninderivate | |
| IL135536A0 (en) | Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same | |
| ES2122145T3 (es) | Fosfiniloximetil-cetonas peptidicas como inhibidores de la enzima convertida de la interleuquina-1 beta. | |
| NO902394L (no) | Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater. | |
| DE68922660D1 (de) | 19-Substituierte Progesterone als 19-Hydroxylase-Inhibitoren. | |
| NO911236L (no) | Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer. | |
| BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
| FI915623A0 (fi) | 2b,19-etylenbryggsteroider som aromatasinhibitorer. | |
| NO892679D0 (no) | Fremgangsmaate for fremstilling av 19-fluor- eller cyano- 21-hydroxyprogesteronderivater. |